Drug intelligence / Profile preview

proparacaine

Development stage
Approved
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

Proparacaine is a rapidly acting local anesthetic of the amino ester group used primarily in ophthalmic practice to numb the eye before procedures such as surgery or diagnostic tests. It works by stabilizing neuronal membranes and inhibiting the ionic fluxes required for initiation and conduction of nerve impulses. The main mechanism involves antagonism of voltage-gated sodium channels at the nerve cell membrane in the cornea and conjunctiva. This action blocks pain signals at nerve endings in the eye and provides short-duration anesthesia (onset within 30 seconds; duration 10–20 minutes). Proparacaine is indicated for topical anesthesia during tonometry, removal of foreign bodies or sutures from the cornea, conjunctival scraping for diagnosis, gonioscopic examination, and prior to surgical operations such as cataract extraction[1][2][3][7].

Brand names
AlcaineAK-TaineOcu-CaineOphthaineOphtheticParcaine
Other names
proparacaine hydrochlorideproxymetacaine
02

Targets

NaV (Voltage-gated sodium channels)

Beyond the preview

Go deeper on proparacaine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on proparacaine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call